A combined analysis of lesion severity and diabetes status found no difference in PPARα, or ACOX1, but a significant increase of CPT1A (p < 0.05) in Max segments in individuals without diabetes (Figures 6G–I) as demonstrated by western blot analysis (Figure 6J). This evidence concerns the gene CPT1A and diabetes mellitus.